JPMorgan Chase & Co’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.97M Buy
953,080
+256,637
+37% +$531K ﹤0.01% 3351
2025
Q1
$1.53M Buy
696,443
+133,679
+24% +$294K ﹤0.01% 3416
2024
Q4
$861K Buy
562,764
+356,053
+172% +$545K ﹤0.01% 3884
2024
Q3
$411K Buy
206,711
+154,487
+296% +$307K ﹤0.01% 4131
2024
Q2
$183K Buy
52,224
+9,740
+23% +$34.1K ﹤0.01% 4313
2024
Q1
$118K Sell
42,484
-33,137
-44% -$91.8K ﹤0.01% 4674
2023
Q4
$129K Sell
75,621
-6,734,321
-99% -$11.4M ﹤0.01% 4660
2023
Q3
$7.01M Sell
6,809,942
-45,669
-0.7% -$47K ﹤0.01% 2223
2023
Q2
$7.95M Sell
6,855,611
-231,180
-3% -$268K ﹤0.01% 2198
2023
Q1
$10.7M Buy
7,086,791
+332,792
+5% +$503K ﹤0.01% 1950
2022
Q4
$16.9M Buy
6,753,999
+59,315
+0.9% +$148K ﹤0.01% 1544
2022
Q3
$28.3M Sell
6,694,684
-190,993
-3% -$806K ﹤0.01% 1204
2022
Q2
$19.2M Buy
6,885,677
+759,541
+12% +$2.12M ﹤0.01% 1461
2022
Q1
$35M Sell
6,126,136
-128,630
-2% -$736K ﹤0.01% 1224
2021
Q4
$57.1M Buy
6,254,766
+952,969
+18% +$8.7M 0.01% 1031
2021
Q3
$56.7M Buy
5,301,797
+791,695
+18% +$8.46M 0.01% 1028
2021
Q2
$70M Buy
4,510,102
+1,236,981
+38% +$19.2M 0.01% 989
2021
Q1
$53.1M Buy
3,273,121
+172,339
+6% +$2.79M 0.01% 1050
2020
Q4
$65.6M Buy
3,100,782
+122,187
+4% +$2.59M 0.01% 875
2020
Q3
$44.2M Buy
2,978,595
+141,188
+5% +$2.1M 0.01% 947
2020
Q2
$41.7M Buy
2,837,407
+259,665
+10% +$3.82M 0.01% 907
2020
Q1
$30.3M Buy
2,577,742
+555,540
+27% +$6.52M 0.01% 942
2019
Q4
$47.5M Buy
2,022,202
+486,493
+32% +$11.4M 0.01% 890
2019
Q3
$28.4M Buy
1,535,709
+110,192
+8% +$2.04M 0.01% 1153
2019
Q2
$26.3M Buy
1,425,517
+535,821
+60% +$9.88M 0.01% 1190
2019
Q1
$21.7M Buy
889,696
+677,354
+319% +$16.6M ﹤0.01% 1297
2018
Q4
$5.51M Buy
212,342
+5,540
+3% +$144K ﹤0.01% 2047
2018
Q3
$6.55M Sell
206,802
-10,262
-5% -$325K ﹤0.01% 2082
2018
Q2
$8.43M Sell
217,064
-25,747
-11% -$1M ﹤0.01% 1927
2018
Q1
$6.7M Sell
242,811
-42,397
-15% -$1.17M ﹤0.01% 2014
2017
Q4
$5.16M Buy
285,208
+283,000
+12,817% +$5.12M ﹤0.01% 2228
2017
Q3
$35K Buy
2,208
+164
+8% +$2.6K ﹤0.01% 3874
2017
Q2
$28K Sell
2,044
-67,308
-97% -$922K ﹤0.01% 3861
2017
Q1
$1.04M Buy
69,352
+1,897
+3% +$28.5K ﹤0.01% 2879
2016
Q4
$884K Buy
67,455
+2,363
+4% +$31K ﹤0.01% 3039
2016
Q3
$1.12M Sell
65,092
-271,796
-81% -$4.68M ﹤0.01% 2706
2016
Q2
$6.08M Sell
336,888
-11,797
-3% -$213K ﹤0.01% 1907
2016
Q1
$6.62M Buy
348,685
+19,737
+6% +$375K ﹤0.01% 1818
2015
Q4
$8.78M Buy
328,948
+156,259
+90% +$4.17M ﹤0.01% 1669
2015
Q3
$4.21M Buy
+172,689
New +$4.21M ﹤0.01% 2041
2015
Q1
Sell
-17,469
Closed -$176K 3465
2014
Q4
$176K Buy
+17,469
New +$176K ﹤0.01% 3308